The Killer Immune Cells Behind Exceptional Longevity

Key takeaways

• People who live past 110 carry markedly higher levels of a rare immune cell type called CD4 cytotoxic T cells, rising from about 4% in people ages 70 to 99 to nearly 18% in those 110 and older.
• These cells often expand into large clusters of nearly identical copies, a sign the immune system has been mounting sustained, targeted responses over time.
• Some of these expanded immune cell clusters closely matched patterns associated with recognizing abnormal cells, even though the study's oldest participants had no history of related conditions.
• The bigger picture: exceptional longevity may be linked less to an immune system that quiets down with age and more to one that stays actively engaged and adaptive into extreme old age.

What supercentenarians' blood reveals

Supercentenarians, people who live to 110 or beyond, are rare enough that studying their biology offers a genuine glimpse into what exceptional aging can look like. Researchers in Japan examined blood samples from 28 adults across three age groups, ages 70 to 99, 100 to 109, and 110 and older, looking for patterns in immune cell composition that might distinguish the oldest group.

What they found centered on a distinctive, relatively rare type of immune cell.

A rare immune cell that keeps showing up

The cells in question, CD4 cytotoxic T lymphocytes, are known for their ability to identify and eliminate abnormal cells. Across the three age groups, the median share of these cells in circulating blood rose steadily, from 4% in the youngest group to 9.6% in centenarians and 17.6% in supercentenarians.

That climb suggests something is happening with this cell population specifically as people cross into extreme old age, rather than a general immune shift that applies evenly across all cell types.

Signs of a targeted, ongoing immune response

To understand why these cells were so abundant, researchers looked at the immune receptors on individual cells. They found that many of the CD4 cytotoxic T cells in a given person weren't a random mix, they were large clusters of nearly identical cells, a pattern that arises when the immune system repeatedly copies a specific cell in response to an ongoing challenge.

In some participants, a single cluster made up more than half of all CD4 cytotoxic T cells sampled. When researchers compared the receptor patterns of these dominant clusters to public reference data, many matched patterns previously seen in people whose immune systems were responding to abnormal cell activity, even though the supercentenarians in this study had no such diagnosed history themselves.

A longevity lens: an immune system that keeps working

This research adds a compelling data point to a broader story in aging science: immune aging isn't simply decline. It may also involve ongoing adaptation, with certain cell populations continuing to specialize and respond to internal changes well into extreme old age.

As the study's authors put it, cells that behave abnormally tend to become more common as we age, so an immune system capable of continuing to recognize and respond to that shift, rather than gradually losing the ability to notice it, may be part of what separates typical aging from exceptional aging.

The takeaway

This is early, observational work in a very small and unusual group, so it can't yet tell us whether having more of these cells actually helps people live longer or is simply a byproduct of having lived so long. But it reframes a useful question: instead of asking how to keep the immune system quiet as we age, it may be worth asking how to keep it engaged, specific, and responsive, the way it appears to be in people who make it past 110.

References:

Kosuke Hashimoto, Miki Kojima-Ishiyama, Hajime Inokuchi, Michihira Tagami, Takashi Sasaki, Kenji Mizuguchi, Yasushi Okazaki, Ichiro Taniuchi, Kazuyoshi Ishigaki, Nobuyoshi Hirose, Piero Carninci, Yasumichi Arai. CD4 CTLs in supercentenarians: Signs of adaptive expansion in healthy aging. Cell Reports, 2026; 117728 DOI: 10.1016/j.celrep.2026.117728